This site is intended for healthcare professionals only
LoginRegister
Eli Lilly gets USFDA Breakthrough Therapy designation for olomorasib with Keytruda for lung cancerEli Lilly collaborate with API to launch obesity Gurukul for obesity care in India
Moderna Spikevax gets full USFDA nod for kids 6 months through 11 years at increased COVID riskModerna Spikevax gets full USFDA nod for kids 6 months through 11 years at increased COVID risk
USFDA approves Caplin Steriles Milrinone Lactate in 5% Dextrose Injection, Infusion bagsMerck Animal Health gets USFDA nod for Bravecto Quantum to protect dogs from fleas, ticks
PfizerPfizer Gets CDSCO Panel Nod To Conduct Phase III Trial of RSV Vaccine in India, Told to Clarify...
Bayer Gadoquatrane new drug application accepted for review by USFDABayer seeks EMA nod for Gadoquatrane
Violation of Nursing Home Registration Act: Maharashtra cancels Licenses of 258 Private Hospitals4 Pharma Firms Lose Licenses Over Pregabalin, Tapentadol Misuse
CDSCO Panel Allows Ravenbhel to Conduct BE, Phase III Trial of Dapagliflozin, Sacubitril, Valsartan FDCUnreadable Expiry Dates, Generic Mix-Ups: Govt Panel Proposes Forming Sub-Committee on Medicine...
Child Given Wrong Injection at Government HospitalSEC Flags Safety, Efficacy Gaps in Troikaa's Rapid IV Paracetamol Bolus Proposal, Seeks More Data
Panacea Biotec announces listing of EmulsiPan adjuvant in CEPI Adjuvant LibraryPanacea Biotec, Apotex resolve dispute over breach of collaboration agreement
India seeks to boost drug exports to semi regulated markets in Africa, Latin America, Southeast AsiaDelay implementation of ONDLS-only COPP submission model: Pharmexcil requests CDSCO, Health Ministry
Racket manufacturing fake medicines busted, factory owner heldOver 5300 bottles of fake cough syrup seized, 1 arrested
Novartis loses legal battle to block US Entresto generic until 2026Novartis loses legal battle to block US Entresto generic until 2026
X